Clinical Trials Related to Ciltacabtagene Autoleucel

Related studies linked through entity extraction aliases.

Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma

Status: RECRUITING
Phase: PHASE1

Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

Status: RECRUITING
Phase: PHASE2

The Norwegian Immunotherapy in Multiple Myeloma Study

Status: RECRUITING
Phase: N/A

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Status: RECRUITING
Phase: PHASE1

CAR- PRISM (PRecision Intervention Smoldering Myeloma)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2